Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- Risky claims for skincare in the UK are those that suggest therapeutic, curative, or preventive properties for medical conditions, such as ‘anti-acne’ or ‘heals eczema,’ as they may be classified as medicinal products under the UK Medicines and Healthcare products Regulatory Agency (MHRA) or UK Cosmetics Regulations.
- To avoid medical claims, stick to cosmetic functions like cleansing, moisturizing, or improving appearance, and ensure all marketing and labels are reviewed for compliance with UK-specific guidelines, including post-Brexit UKCA or retained EU standards.
- Our factory supports this through formulation checks, where we assess ingredient lists and claim substantiation during the R&D phase, using in-house labs for stability and safety testing to provide documentation like product information files (PIFs) and safety reports.
- For practical execution, MOQs typically start at 5,000-10,000 units per SKU, influenced by custom formulations and packaging complexity; sampling takes 4-6 weeks from RFQ approval, including claim validation and label mock-ups.
- We integrate QA checkpoints such as microbial hold-time tests and viscosity controls to ensure consistency, and packaging is designed to avoid misleading imagery or text, with lead times of 8-12 weeks post-production for shipping, including compliance document preparation like certificates of analysis and UK-specific declarations.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
